Key Takeaways
These points summarize how this five-phase roadmap can help you approach a sale with clearer expectations and better information.
-
Selling a dental practice can be one of the most consequential financial decisions in a dentist’s career, and the information gap between owners and DSOs can be some of the main factors that reduce seller outcomes.
-
This five-phase roadmap walks through each step, from assembling the right team to estimating what you actually walk away with after taxes, debt, and fees.
-
The guide focuses on two areas many resources gloss over: how to choose between a private buyer and a DSO, and how to think about your net proceeds.
-
As noted later in Phase 2, McLerran & Associates works both transition paths regularly, which supports a genuine side-by-side comparison for owners.
-
McLerran & Associates is a dental-only sell-side advisor with approximately 35 years in business, roughly 2,000 successful practice sales, and approximately $2 billion in closed transaction volume.
Schedule a free, confidential discovery call with McLerran & Associates.
Steps in a summary
-
Define Your Goals And Assemble Your Team. Clarify your “why” and bring in a dental-specific CPA, attorney, and sell-side advisor before you talk to any buyer.
-
Choose Your Path: Private Buyer Vs. DSO. Compare valuation basis, timeline, clinical autonomy, and what you keep on each path before deciding.
-
Get A Real Valuation. A CPA-led EBITDA analysis, with every add-back unpacked, can hold up under buyer scrutiny and reduce re-trading risk. EBITDA stands for earnings before interest, taxes, depreciation, and amortization, a measure of a practice’s true operating profit.
-
Prepare And Go To Market. Protect confidentiality, build your marketing profile, and run a competitive process among vetted buyers.
-
Negotiate, Diligence, And Close. Negotiate the letter of intent, defend your quality of earnings, and understand what you actually net after taxes, debt, and fees.
Phase 1: Define Your Goals And Assemble Your Team
Selling a dental practice is a multi-phase transaction in which the owner transfers the clinical and business assets of the practice to a buyer. The buyer can be another dentist in a private, doctor-to-doctor sale or a DSO or private equity partner in an affiliation. The transfer follows a valuation, a confidential marketing process, and a negotiated purchase agreement.
Owners benefit from clarifying their own “why” before any number is discussed with any buyer. Some want relief from the burden of running a large organization, including staff issues and early-morning crises. Others want to take some chips off the table while staying clinically active. Many are planning an eventual full exit and want to protect the patients and staff they will leave behind. The right transition path can depend heavily on which of these motivations drives the decision.
The advisor team matters as much as the motivation. Three specialists usually help most before any buyer conversation begins, and they work together to protect both value and relationships.
-
A dental-specific CPA understands add-backs, EBITDA normalization, and purchase price allocation. Purchase price allocation means dividing the sale price across asset categories such as equipment, goodwill, and non-compete agreements in a way that determines how each dollar is taxed.
-
A dental M&A attorney reviews letters of intent, negotiates representations and warranties, and protects the seller’s interests through closing.
-
A dental-specific sell-side advisor serves as an advocate who controls the narrative around the practice’s profitability, creates competition among buyers, and represents only the seller’s interests.
The distinction between a sell-side advisor and a listing agent can affect both price and experience. A listing agent posts a practice and waits. A sell-side advisor builds a diligence-grade valuation, runs a structured competitive process, and defends the numbers through due diligence. That work also acts as a buffer, protecting staff relationships and goodwill throughout the transaction. For a deeper look at how to evaluate that choice, see How to Choose the Right Dental Practice Broker.
Confidentiality is a real concern at this stage. Owners often describe “keeping it quiet” as a top anxiety, including staff finding out early, patients hearing rumors, or an associate leaving prematurely. A well-run process manages disclosure carefully. Anonymized summaries go out first. Detailed financials follow only after a signed non-disclosure agreement. Facility tours usually happen after hours. A dental practice sale should remain strictly confidential until the deal is legally binding, because early disclosure can cause staff anxiety and prompt key team members to interview elsewhere during the period buyers are measuring the business most closely.
Phase 2: Choose Your Path: Private Buyer Vs. DSO
This decision can swing a practice’s value by millions. The two paths differ in how the practice is valued, how long the seller stays involved, how much clinical autonomy remains after the deal, and what the seller actually keeps. Because McLerran & Associates works both paths in roughly equal measure, the firm can produce a true side-by-side valuation rather than steering owners toward whichever path the advisor knows best.
Private Buyer (Doctor-To-Doctor)
In a doctor-to-doctor sale, the buyer is another dentist. Private buyers typically price a practice at a percentage of annual collections or a multiple of net cash flow. They view the purchase as both a job and a business and combine owner compensation, discretionary expenses, and depreciation into a single cash-flow stream. The typical work-back period, meaning the time the seller stays on after closing, is approximately 4–8 weeks for a walk-away sale. The practice philosophy often stays intact because the buyer is another clinician. In a private owner-user sale, the seller typically receives 100% cash at closing with no rollover equity complexity.
A second structure, the partnership or vest-out, can suit larger practices that support two or more doctors. In that model, the seller often sells about 50% now to a future partner who buys the remaining share over time.
DSO / Private Equity
In a DSO affiliation, the buyer is a corporate entity that manages the non-clinical operations of dental offices. DSO and corporate buyers price practices at a multiple of EBITDA. This approach can produce higher headline numbers as practice scale increases, because institutional buyers separate owner compensation into an operating expense and price on true operating profit rather than a combined cash-flow stream.
A standard working agreement of approximately 5 years is common, although a shorter work-back may be possible if the seller has already reduced clinical days. Clinical autonomy is preserved in many DSO transactions in the sense that treatment planning decisions and clinical protocols remain the responsibility of the treating dentist, while non-clinical functions shift to the DSO.
The consideration mix usually includes several pieces. Cash at close provides immediate liquidity. Rollover equity means a portion of the proceeds is reinvested into the DSO platform. Earnout payments tie part of the price to post-close performance targets. A majority of a DSO deal is often cash at close, with a portion in equity, so the seller effectively becomes an investor in the DSO and evaluates it accordingly.
Side-By-Side Comparison
The table below summarizes how the two paths differ on three common decision points: valuation basis, how long the seller stays involved, and how the proceeds are paid.
|
Attribute |
Private Buyer (Doctor-To-Doctor) |
DSO / Private Equity |
|---|---|---|
|
Valuation Basis |
Percentage of revenue or multiple of net cash flow |
Multiple of EBITDA |
|
Typical Work-Back Period |
~4–8 weeks (walk-away sale) |
~5 years (standard working agreement) |
|
Cash-Vs-Equity Mix |
100% cash at closing (typical) |
A majority cash at close, a portion in equity |
With the structural differences clear, the next step is matching each path to the type and size of practice you own.
Which Path Fits Which Practice?
Smaller premier practices, roughly $1–1.5 million in annual revenue, often fit a doctor-to-doctor sale. The largest practices, at $3 million and above, tend to point toward the DSO path, where EBITDA-based pricing can produce materially higher headline numbers. The line between private-buyer-only and institutional-eligible can be one of the most consequential qualifications a dental practice owner can prepare for, because crossing it can multiply the valuation outcome.
Practices in the $1.5–3 million revenue range can genuinely go either way. Those owners often benefit most from a true side-by-side valuation across both markets.
Find out what your practice is really worth — request a comprehensive practice valuation.
Phase 3: Get A Real Valuation
A serious valuation usually triangulates three methods: percentage of collections, discounted cash flow (DCF), and comparable sales. A wide gap between them can signal that revenue and profitability have drifted apart. Overhead creep, a weak fee schedule, or dependence on low-reimbursement insurance plans can be some of the main factors behind that drift.
The 50-40-30 Rule
The 50-40-30 rule is an overhead benchmark used to assess dental practice profitability at different scales: overhead should be no more than 50% of collections for a solo practice, 40% for a small group, and 30% for a mature DSO platform. Buyers apply it as a quick profitability screen before committing to full diligence. A practice running overhead above these benchmarks signals an immature management structure and uncontrolled location-level costs, which can compress the multiple offered.
Why “Free” Valuations Anchor Low
A back-of-the-napkin number set by a buyer or a lead-generation firm often becomes the anchor that quietly determines what the owner walks away with. A weak valuation analysis gets “eaten alive” in due diligence, and the deal can be re-traded. Re-trading means the buyer uses diligence findings to push the price down after the seller has already committed to exclusivity and stopped talking to other buyers.
A CPA-led EBITDA analysis, with every add-back documented and defensible, tends to hold up when buyers scrutinize it. McLerran & Associates builds this diligence-grade work up front, so the numbers are more likely to remain stable when a buyer’s quality-of-earnings team reviews them.
What Moves The Multiple
Multiples are driven by fundamentals rather than a fixed table. Larger practices with more doctors, room to expand, durable revenue, and higher EBITDA often command higher multiples. Specialty can also influence valuation. Oral and maxillofacial surgery and orthodontics tend to command elevated multiples relative to general dentistry, while general dentistry still earns aggressive, near-all-time-high valuations.
Practices where the selling owner generates a large share of collections personally may see buyers reduce their EBITDA underwrite before applying a multiple. That adjustment can erase a significant portion of headline value. McLerran does not promise a specific multiple. Your multiple is shaped by your specific numbers and market, which is exactly what a diligence-grade valuation quantifies.
Phase 4: Prepare And Go To Market
Going to market with a clear confidentiality plan can protect both value and relationships. Confidentiality in a dental practice sale is a value-protection issue because staff, patients, associates, and referral relationships can react negatively to unmanaged rumors, potentially damaging performance during the period buyers are measuring the business most closely. Buyers typically receive an anonymized summary before learning the practice’s identity, with more detailed disclosure staged behind signed non-disclosure agreements and buyer qualification.
The DSO Bid Process
For DSO transactions, McLerran & Associates runs a structured, auction-like bid process that usually lasts 45–60 days among a vetted, pre-qualified pool of buyers. The process generally generates around 10 offers per listing and then narrows to in-person meetings with the top 1–3 finalists. Poorly run DSOs stay off the list entirely.
Dental practices taken to market through a structured multiple-buyer solicitation process can receive final sale values meaningfully above initial unsolicited offers. An owner who responds to a single inbound DSO letter negotiates from a significant information disadvantage, similar to playing checkers against a counterparty playing chess.
The Private-Buyer Process
For doctor-to-doctor transactions, McLerran accesses a large premier private-buyer pool, including thousands of pre-qualified buyers, and markets through multiple channels such as direct mail, geofencing, and study-club relationships. The goal is to secure an at- or above-ask offer from a well-qualified buyer who will preserve the practice’s goodwill, care for its patients, and protect its staff.
Many owners also ask whether an associate can buy the practice. The answer depends on the associate’s financial position, the practice’s size, and available financing structures. McLerran evaluates this as part of the buyer qualification process rather than assuming the outcome.
Phase 5: Negotiate, Diligence, And Close
The letter of intent (LOI) is the document where the deal takes shape. It captures price, structure, and timeline before attorneys draft the binding purchase agreement. Material business issues in a dental practice sale should be negotiated and reflected in the letter of intent rather than left for the definitive documents stage, because once exclusivity is in place, a seller’s flexibility to modify economic or structural terms is often reduced.
Purchase prices are adjusted in a significant share of dental practice transactions after due diligence, usually downward, due to equipment condition, accounts receivable quality, or undisclosed lease issues. McLerran defends the EBITDA it underwrote when the buyer’s quality-of-earnings team challenges the numbers and reminds buyers that other vetted bidders are waiting if they attempt to re-trade the deal.
Close rates can vary widely. Do-it-yourself close rates often run lower, while McLerran clients tend to experience higher completion rates compared with an industry norm closer to 35–40%. The fragility of the process is real. Deals can collapse at multiple points before closing, and without an experienced advisor to mitigate problems and protect momentum, they frequently do.
What Do You Actually Walk Away With? A Net-Proceeds Reality Check
The headline number on a dental practice sale rarely matches the amount that lands in the seller’s account. Several items reduce that figure, and understanding each one before signing an LOI can be the difference between a satisfying exit and a disappointing one.
-
Taxes. Most dental practice transactions are structured as asset sales, with purchase price allocated across goodwill, equipment, and non-compete payments. Goodwill is generally taxed at long-term capital gains rates for the seller. Equipment can be subject to depreciation recapture as ordinary income. Non-compete payments are taxed as ordinary income. Under the IRC Section 1245 recapture rule, gain attributable to prior depreciation on equipment is taxed at ordinary income rates, up to 37% federally, regardless of how long the asset was held. Goodwill, by contrast, is generally taxed at long-term capital gains rates. The top combined federal rate on capital gains is 23.8% before state tax, consisting of the 20% long-term capital gains rate plus the 3.8% Net Investment Income Tax (NIIT) that applies to higher-income sellers. State income tax adds further, ranging from 0% in states with no income tax to more than 13% in high-tax states. Consult your tax advisor; this article is education, not tax advice.
-
Debt Payoff. Practice debt is usually settled out of the sale price before the seller receives proceeds.
-
Advisor And Legal Fees. Transaction-related costs, including sell-side advisory fees, legal fees, and other closing costs, reduce net proceeds.
-
Cash-Vs-Equity-Vs-Earnout Mix. The true value of rollover equity in a dental practice sale depends on governance rights, dilution protections, capital structure, and the timing, terms, and possibility of any future exit. Retained equity is not cash. It waits for the buyer’s own sale, which may be years away and may not occur at a favorable price. Earnout payments tied to post-close performance targets may never arrive if targets are not met. A private dental practice sale paid in full at closing may outperform a DSO offer with an earnout component once taxes, deferred payment risk, and post-sale obligations are considered.
McLerran produces multi-year, multi-structure financial forecasting that models what each path can net the owner over time across 3-, 5-, 7-, and 10-year horizons. Owners can then compare real after-tax proceeds across deal structures rather than guessing from a headline number.
Frequently Asked Questions
How Much Should A Dental Practice Sell For?
There is no single answer, and any advisor who gives a fixed number without reviewing your financials is guessing. Private sales can price at a percentage of annual collections or a multiple of net cash flow. DSO deals price at a multiple of EBITDA. Larger practices with more doctors, room to expand, durable revenue, and higher EBITDA often see higher multiples. Specialty can also influence valuation, with oral and maxillofacial surgery and orthodontics often commanding elevated multiples relative to general dentistry. A diligence-grade valuation tailored to your numbers, market, and buyer pool provides the clearest estimate.
What Is The 50-40-30 Rule In Dentistry?
The 50-40-30 rule, introduced in Phase 3, sets overhead ceilings of 50%, 40%, and 30% of collections for solo, small-group, and mature DSO platforms respectively. Buyers often use this rule as a quick profitability screen before full diligence. Practices that reduce overhead closer to these benchmarks can improve EBITDA, which then feeds into a higher valuation multiple.
Do I Have To Pay Taxes If I Sell My Dental Practice?
Most dental practice transactions trigger tax obligations. Many deals use an asset-sale structure, with purchase price allocated across goodwill, equipment, and non-compete payments. Much of a DSO deal can qualify for long-term capital gains treatment rather than ordinary income, but the mix depends heavily on how the purchase price is allocated across asset categories. That allocation is negotiated during the deal. State income tax applies on top of federal rates and varies significantly by state. A tax advisor who understands practice sales can help you plan ahead, and many effective strategies require advance restructuring.
How Do I Value My Dental Practice?
A practical approach uses three methods together: percentage of collections, discounted cash flow, and comparable sales. A CPA-led EBITDA analysis, with every add-back documented and defensible, can help prevent re-trading during diligence. The percentage-of-collections method is fast and commonly used in casual conversation, but it says nothing about profitability. DCF projects future cash flows and discounts them to present value, accounting for risk, and it is the method institutional buyers and larger DSOs tend to run internally. Comparable sales anchor the valuation in what buyers are actually paying in a given market.
Not sure if selling is right for you yet? Join the McLerran M&A Summit, October 29–30, 2026.
Conclusion: Why The Right Advocate Matters For A Once-In-A-Career Decision
A dental practice owner usually sells once in a lifetime, while a DSO negotiates every week. That difference in information, experience, and negotiating leverage can shape the outcome of a transition. The valuation can swing by millions depending on who is in the room. The process is fragile and can collapse at multiple points before closing. The financial mechanics of a DSO deal, including cash, equity, earnouts, purchase price allocation, and tax treatment, are complex enough that even sophisticated owners can walk away with far less than they expected.
McLerran & Associates exists to narrow that gap. The firm is a dental-only sell-side advisor and advocate that never represents the buyer. Its track record reflects that focus: approximately 35 years in business, roughly 2,000 successful practice sales, approximately $2 billion in closed transaction volume, and more than 10,000 practices evaluated. As noted earlier, the firm’s roughly even split between private-buyer and DSO transactions supports a genuine side-by-side valuation across both paths. The structured, auction-like bid process, which typically generates around 10 offers per DSO listing, creates competitive tension that can push prices up and improve terms for the seller. The firm’s approximately 85–90% transaction rate, compared with an industry norm closer to 35–40%, illustrates what can happen when diligence-grade work, a vetted buyer pool, and experienced advocacy come together in a single engagement.
For owners considering a transition now or 12–36 months from now, a free, confidential discovery call can be a useful first step. No commitment is required, and no buyer will know you called.
You can also explore How To Sell A Dental Practice Without A Broker to understand what going it alone actually involves and what it can cost.
Schedule a free, confidential discovery call with McLerran & Associates.
